To investigate how intrinsic affinity of the separate arms and format of a bsAb molecule regulates selective targeting under physiological conditions, we selected the human NCI-H358 cell line as a tumor model and the anti-HER2 trastuzumab and anti-EGFR GA201 as model antibodies. The gene discussed is EGFR; the disease is neoplasm.